ArticleBMJ open gastroenterology2025
Deep learning and capsule endoscopy: automatic panendoscopic detection of protruding lesions.
Article in BMJ open gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Artificial Intelligence in Gastrointestinal Wireless Capsule Endoscopy: A Systematic Literature Review and Meta-Analysis.Diagnostics (Basel, Switzerland) · 2026Review
- Robotic Capsule Endoscopy: Simultaneous Gastric and Enteric Evaluation in Real-World Practice.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveCapsule endoscopy (CE) provides a minimally invasive exam modality for panendoscopic evaluation of the entire gastrointestinal (GI) tract. However, conventional reading methods can be time-consuming and error-prone. Protruding lesions are a relatively common entity that can be found with a variable incidence and different pathological significance throughout the GI tract. The aim of this study was to develop and test a convolutional neural network (CNN)-based algorithm for panendoscopic automatic detection of protruding lesions on CE exams.
methodsA multicentric retrospective study was conducted, based on 1245 CE exams. We used a total of 191 455 frames, from six types of CE devices, of which 52 717 had protruding lesions (polyps, epithelial tumours or subepithelial lesions) after triple validation. Data were divided into a training and test set (90% vs 10%), in an exam-split design. During the training stage, we performed a fivefold cross-validation. Our outcome measures were sensitivity, specificity, accuracy, positive predictive value (PPV), negative predictive value (NPV), and areas under the conventional receiver operating characteristic curve (AUC-ROC) and the precision-recall curve (AUC-PR).
resultsIn the test set, the sensitivity was 79.7% and the specificity was 96.5%. The PPV and NPV were 81.5% and 96.0%, respectively. The global accuracy was 93.7%.
conclusionThis study aims to address a gap in artificial intelligence (AI)-enhanced capsule panendoscopy by reporting the development of the first CNN for the detection of protruding lesions across the GI tract. AI's improvement of CE's diagnostic accuracy, along with the growing interest in minimally invasive procedures, may contribute to increasing access to this diagnostic tool. Further multicentric and prospective studies are needed to validate our preliminary results to ultimately introduce deep learning models into clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.